5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Biomaterials Market is segmented by Type of Biomaterial (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, and Polymeric Biomaterial), Application, and Geography.
Fastest Growing Market:
The biomaterials market is expected to register a CAGR of 13.69%. Certain factors that are driving the growth of this market are new innovations in the field of biomaterials, growing implant devices and plastic surgery market, and increasing applications of biomaterials in wound care/ sports injury.
Biomaterials are substances that have been engineered to interact with biological systems for a medical purpose, either a therapeutic (treat, augment, repair, or replace a tissue function of the body) or a diagnostic one.
|By Type of Biomaterial|
Report scope can be customized per your requirements. Click here.
In the application segmentation of the biomaterials market, the orthopedics segment is believed to register the highest CAGR over the forecast period.
The orthopedics application of biomaterials is majorly comprised of bone graft substitutes, which include allograft, autograft, demineralized bone matrix, bone morphogenetic proteins, cell-based matrices, and synthetic bone graft substitutes.
BMP-2 (INFUSE), a recombinant DNA product, is one of the most renowned products by Medtronic that helps in faster fracture healing.
Bone graft substitutes find most of their applications in spinal fusion, trauma fixation, joint reconstruction, craniomaxillofacial fixation, dental fixations, and other applications. Growth factor enhanced grafts are expected to have a high growth rate in the market studied. This includes human growth factors or morphogens. There is a shift from autologous/allogeneic bone graft substitutes to synthetic bone graft substitutes. The technological advancements for better osteoinductivity, osteoconductivity, and osteogenicity are expected to propel the growth of the market studied.
To understand key trends, Download Sample Report
The biomaterials market is growing at a fast rate in India. Orthopedic, dental, and cardiovascular biomaterials have a considerable share in the Indian biomaterials market. The increasing orthopedic procedures, dental surgeries, and cardiovascular surgeries are the reasons for high market shares of orthopedic and cardiovascular biomaterial products.
Due to the high prevalence of cardiac disorders and increasing pacemaker procedures in India, the market for pacemakers is expected to have consistent demand and a steady growth rate during the forecast period.
Medtronic is a market leader in pacemakers. There is a high rate of angioplasty with stent placement and a parallel demand for the same. The Indian biomaterials market is experiencing growing demand for bone graft substitutes, and the market studied for the same is anticipated to rise during the forecast period.
To understand geography trends, Download Sample Report.
The biomaterials market is moderately competitive. Some of the companies that are well known in this market are Koninklijke DSM NV, Corbion NV, Biomet Inc., Noble Biomaterials Inc., and Bayer AG. Currently, with the rising focus of all the companies on emerging economies, some of the small and mid-sized companies are also penetrating the market and competing for market share.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 New Innovations in the Field of Biomaterials
4.2.2 Increasing Implant Devices and Plastic Surgery Market
4.2.3 Increasing Applications of Biomaterials in Wound Care/Sports Injury
4.3 Market Restraints
4.3.1 Compatibility Issues
4.3.2 Stringent Regulatory Guidelines
4.3.3 High Price of the Implantable Biomaterials
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type of Biomaterial
5.1.1 Natural Biomaterial
5.1.2 Metallic Biomaterial
5.1.3 Ceramic Biomaterial
5.1.4 Polymeric Biomaterial
5.2 By Application
5.2.5 Wound Care
5.2.7 Plastic Surgery
5.2.8 Other Applications
5.3.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle-East and Africa
5.3.5 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BASF SE
6.1.2 Dentsply International
6.1.3 Noble Biomaterials Inc.
6.1.4 Biomet Inc.
6.1.5 Carpenter Technology Corporation
6.1.6 Bayer AG
6.1.7 Royal DSM
6.1.8 Corbion NV
6.1.9 Berkeley Advanced Biomaterials Inc.
6.1.10 Victrex PLC
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments